Kleiner Perkins-backed Ambiq pops on IPO debut

Ambiq Micro, a manufacturer specializing in energy-efficient chips for both wearable and medical devices, made a striking debut on the stock market. On its initial trading day, the company’s shares closed at $38.53, reflecting a remarkable 61% surge from the $24 IPO price set just a day prior. This strong performance underscores a robust appetite among investors for emerging small-cap firms that are poised to leverage advancements in artificial intelligence. By the end of its first trading day, Ambiq achieved a valuation of $656 million, excluding employee options. This figure marks a substantial increase from its last private funding valuation of $450 million recorded earlier in 2023, as noted by PitchBook. Ambiq has positioned itself as a frontrunner in the AI-driven market, with its Chief Technology Officer, Scott Hanson, emphasizing the company’s low-energy solutions. He stated, “Because we’re so low energy, we can put more intelligence and more AI on board” of edge processors. In terms of financial performance, Ambiq reported a net loss of $8.3 million for the three-month period ending March 31, countered by revenues of $15.7 million, according to its S1 filing. This represents a slight improvement compared to the first quarter of 2024, when the company faced a loss of $9.8 million on $15.2 million in revenue. Significant investments have come from notable backers, including Kleiner Perkins and EDB Investments, a Singaporean state-backed entity. Wen Hsieh, who was a general partner at Kleiner Perkins until 2023, has been a long-time supporter, initially investing in Ambiq during its Series C funding round in 2014 and continuing his support through his venture firm, Matter Venture Partners, which he founded two years ago.